Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics
PR Newswire —
Latest fundraising efforts accelerate further innovation in biology-based diagnostics and therapeutics for critical care conditions CHICAGO, Jan. 29, 2026 /PRNewswire/ -- Prenosis, a biology-based technology company delivering integrated diagnostics and therapeutics, announced today two...